Fertility and IBD: Understanding Different Variables in Women Is Crucial by Consultant360

Schizophrenia is not a death sentence, says Dr Robert S Laitman from Bronx Westchester Medical Group and SARDAA. In part 2 of his podcast series with Consultant360, Dr Laitman explains how his approach to treatment has helped the majority of his patients achieve meaningful recovery. For more, visit www.consultant360.com.

Schizophrenia is not a death sentence, says Dr Robert S Laitman from Bronx Westchester Medical Group and SARDAA. In part 2 of his podcast series with Consultant360, Dr Laitman explains how his approach to treatment has helped the majority of his patients achieve meaningful recovery. For more, visit www.consultant360.com.

Schizophrenia is not a death sentence, says Dr Robert S Laitman from Bronx Westchester Medical Group and SARDAA. In part 2 of his podcast series with Consultant360, Dr Laitman explains how his approach to treatment has helped the majority of his patients achieve meaningful recovery. For more, visit www.consultant360.com.

Schizophrenia is not a death sentence, says Dr Robert S Laitman from Bronx Westchester Medical Group and SARDAA. In part 2 of his podcast series with Consultant360, Dr Laitman explains how his approach to treatment has helped the majority of his patients achieve meaningful recovery. For more, visit www.consultant360.com.

Dr Saira Sheikh from University of North Carolina at Chapel Hill discusses the lack of diversity in Lupus clinical trials, the new ACR partnership aimed at increasing access to trials for minorities, the overall impact on the rheumatologist's ability to manage patients, and more.

Dr Saira Sheikh from University of North Carolina at Chapel Hill discusses the lack of diversity in Lupus clinical trials, the new ACR partnership aimed at increasing access to trials for minorities, the overall impact on the rheumatologist's ability to manage patients, and more.

Dr Saira Sheikh from University of North Carolina at Chapel Hill discusses the lack of diversity in Lupus clinical trials, the new ACR partnership aimed at increasing access to trials for minorities, the overall impact on the rheumatologist's ability to manage patients, and more.

Dr Saira Sheikh from University of North Carolina at Chapel Hill discusses the lack of diversity in Lupus clinical trials, the new ACR partnership aimed at increasing access to trials for minorities, the overall impact on the rheumatologist's ability to manage patients, and more.

Dr Jean-Frederic Colombel from Mount Sinai Medical Center discusses clinical challenges in inflammatory bowel disease for 2019, the need for a multidisciplinary approach, and more.